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Abstract
Background: In response to Mtb infection, the host remodels the infection foci into a dense mass of cells known as the
granuloma. The key objective of the granuloma is to contain the spread of Mtb into uninfected regions of the lung.
However, it appears that Mtb has evolved mechanisms to resist killing in the granuloma. Profiling granuloma transcriptome
will identify key immune signaling pathways active during TB infection. Such studies are not possible in human granulomas,
due to various confounding factors. Nonhuman Primates (NHPs) infected with Mtb accurately reflect human TB in clinical
and pathological contexts.
Methodology/Principal Findings: We studied transcriptomics of granuloma lesions in the lungs of NHPs exhibiting active
TB, during early and late stages of infection. Early TB lesions were characterized by a highly pro-inflammatory environment,
expressing high levels of immune signaling pathways involving IFNc, TNFa, JAK, STAT and C-C/C-X-C chemokines. Late TB
lesions, while morphologically similar to the early ones, exhibited an overwhelming silencing of the inflammatory response.
Reprogramming of the granuloma transcriptome was highly significant. The expression of , two-thirds of all genes induced
in early lesions was later repressed.
Conclusions/Significance: The transcriptional characteristics of TB granulomas undergo drastic changes during the course
of infection. The overwhelming reprogramming of the initial pro-inflammatory surge in late lesions may be a host strategy
to limit immunopathology. We propose that these host profiles can predict changes in bacterial replication and physiology,
perhaps serving as markers for latency and reactivation.
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Introduction
TB is a major public health problem of mankind, responsible for
the death of over 1.7 million people every year [1]. A third of the
world population is infected with Mtb, more than 8 million of
whom develop and ,1.8 million die of TB, each year [1]. This
situation is exacerbated by the emergence of drug-resistant TB [2],
co-infection with AIDS [3] and the failure of Bacille Calmette-
Guerin vaccine [4]. A better understanding of the pathogenesis of
TB is necessary in order to develop effective vaccines. This in turn
requires the availability of robust animal models that accurately
mimic infection [5].
Mouse [6], rabbit [7], guinea pig [8] and NHP models [9–15]
have all contributed to our understanding of TB. Mice are
inexpensive and have been extensively used to study TB from both
the hosts and the pathogens perspective [6,16]. However, mice do
not sufficiently model critical aspects of human TB, such as latency
and the spectrum of pathological lesions [17]. NHPs, such as the
rhesus or the cynomolgus macaques most accurately reflect human
TB in clinical and pathological contexts [9–15].
A hallmark of TB infections is a collection of activated immune
cells, called the granuloma. It is believed that granulomas prevent
the spread of Mtb to other pulmonary and extra-pulmonary sites
[18]. A majority of TB granulomas in human TB exhibit central
necrosis, with a peripheral rim of immune cells. As the disease is
contained, the central necrosis in many lesions is mineralized.
Changes in immune status of the host, e.g. AIDS cause granuloma
failure and reactivation, during which the necrotic areas caseate
[18]. Experimentally infected NHPs can be used to model and
study these lesions. Characterization of TB granulomas could
delineate the cascades of immune signaling patterns and immune
cell recruitment. These studies are impossible to perform in
human lesions due to a number of confounding factors. It is
impossible to verify the dose and infectivity of Mtb strain, the time
elapsed since infection and whether the lesions correspond to
primary or post-primary infection, or re-infection(s). Differences in
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12266geographical location, genetics and the immune status of the host
are also difficult to control. Therefore, NHPs infected with a
defined dose and strain of Mtb, are ideal for the study of TB
granulomas. In this report, we compare the transcriptome profiles
of week 4 (early) vs. week 13 (late/mature) TB lung granulomas of
rhesus macaques.
Results
Enumeration of lymphocytes and their activation status
in the lungs of Mtb-infected NHPs
We studied the temporal recruitment of various lymphocyte
subpopulations (the percentage of CD4+ and CD8+ T cells, and
the percentage of T cells expressing activation [CD69 or HLA-
DR] or apoptosis [CD95] markers) in broncho alveolar lavage
(BAL) of the infected NHPs. Samples were derived from three
different time points (pre-infection, 4 and 12 week post Mtb-
infection) from three different NHPs. The levels of CD3
+ cells
remained relatively constant during the course of Mtb infection of
NHPs (Fig. 1A & B). While the levels of CD4
+ T cells decreased
slightly at 4 weeks post-infection (Fig. 1A), those of CD8
+ T cells
increased slightly at this time, relative to pre-infection (Fig. 1B).
These changes were not significant. The levels of both CD4
+ and
CD8
+ T cells normalized to the pre-infection levels by 12 weeks
post-infection. The relatively constant levels of T lymphocytes
during Mtb infection of NHPs may represent a dynamic
equilibrium between T cells being recruited to the lungs in
response to infection and those being turned over due to tissue
damage.
Despite the fact that the total number of T cells remained
consistent, increased T cell activation was observed following Mtb
exposure. A statistically significant increase in the number of
CD3+CD95+ cells occurred at week 4, relative to pre-infection
(Fig. 1C). CD95 is a member of an apoptotic pathway that plays
an important role in peripheral T cell tolerance, homeostasis and
clonal downsizing of an immune response. It is therefore
considered to be a marker for memory T cells. Particularly in
light of the fact that the total number of lymphocytes was
unchanged, this indicates a transition from naı ¨ve to a memory
phenotype (Fig. 1C). At week 12, the percentage of lymphocytes
expressing CD95 declined slightly relative to week 4. However,
this decline was statistically insignificant.
We also observed an increase in the number of CD69
+ T cells in
BAL at the week 4 time point (Fig. 1D). This increase was reversed
during the chronic (12 weeks post infection) phase of Mtb infection
(Fig. 1D). CD69, an early lymphocyte activation marker, acts as a
co-stimulatory molecule for T cell activation and proliferation.
CD69 is crucial for cytokine response because its stimulation leads
to IL2 production. We also studied the expression of a different
activation marker, HLA-DR on T cells in these samples. The
fraction of HLA-DR
+ T cells significantly increased during the
active (4 wk) phase, relative to pre-infection. The percentage of
these cells declined in the chronic (12 wk) phase, again significantly
(Fig. 1E).
NHP TB lesions appear to be morphologically similar at both 4
and 13 weeks post infection. Moreover, the number of T-
lymphocytes being recruited to the lungs of Mtb infected NHPs,
are comparable between weeks 4 and 12. However, the observed
qualitative differences in lymphocyte activation at these time
points point to functional differences in ‘‘early’’ and ‘‘late’’ primate
TB lung lesions. Therefore, we comprehensively studied gene-
expression profiles of ‘‘early’’ and ‘‘late’’ lesions using rhesus
macaque DNA microarrays.
Global expression analysis in granuloma lesions at week
4 post-Mtb infection
The expression of 3,140 genes was significantly perturbed in
early TB lesions relative to normal lung tissue. The expression of
1,584 genes was enhanced (Table S1), while the expression of
1,556 genes was reduced (Table S2) in early lesions. A short list of
key immune function genes, whose expression was induced or
repressed in early granuloma lesions, are shown in Tables S3 and
S4, respectively.
Genes with a higher level of expression in early TB
granulomas
The expression of numerous chemokine ligands and receptors
(CXCL1, 2, 3, 6, 9, 10, 11, 12, 13, 16; R4; CCL3, 4, 11, 13, 15,
18, 19, 20, SICA3; R1, R2); numerous cytokines and their cognate
receptors (IL1a, 1R, 1RAP, 11, 13R, 4R, 6); the IFNc network,
(IFNc; inducible proteins - IFI30, IFI35, IFIT1, IFIT2, IFIT3,
IFITM1, IFITM3, ISG20; receptors - IFNGR1, IFNGR2,
regulators - IRF1, IRF7a, IRF8; and IFN-dependent genes -
INDO, STAT1, STAT5A, JAK); and various members of the
TNF family (ligands - TNF, SF13A, SF13B, LITAF, LTB1;
receptors - RSF1A, RSF4, RSF8; and related genes – AIP1, AIP3,
C1QTNF1, TRAF3, TANK) was significantly induced in early
lesions (Tables S1, S3).
Genes encoding innate immune (a-defensin, TLR4, TLR8,
TICAM1), complement (C1R, C1QBP, C1QA, C1QB, C1S, C2,
C3) and apoptotic factors (BAK1, BCL2L13, BCL2L14, BNIP3,
CASP1, 3, 4, CARD4, GZMA, GZMB, IER3, IER3IP1, PDCD2,
PDCD10), metallothioneins (MT1E, 1F, 1G, 1X, 4); metallopro-
teases (MMP1, MMP2, MMP7, MMP9, MMP14, MMP25,
ADAM1, ADAM8, ADAM17, ADAM19), lymphocyte antigens
(LAG3, CD83, LCP1, LCP2, LY6E, LY86, LY96), major
histocompatibility complex (HLA-A, -B, -E, -F, -DMA, -DMB, -
DPA1, - DQA1, -DRA, -DRB1, -DRB3, -DRB4, -DRB5),
ubiquitination proteins (UBD, UBE2C, 2E, 2J, 2L3, 2L6, 3A,
USP9X, 10, 18), adhesion molecules (ITLN1, ICAM1, ICAM2,
LGALS3, LGALS9, PECAM1, VCAM1); signaling receptors
(RARRES3, RARB1, SRA1, VDR1); growth factors/receptors
(CSF1R, FGF1, IGF1, IGF2R, IGFBP3, IGFBP4, IGFBP7,
PDGFB); transcription factors (CEBPB, CEBPD, CREB3,
CREB3L2, CREB5) and G-protein signaling molecules (RGS1,
S16, S19) exhibited increased expression in the early granulomas
(Table S3).
Genes with a lower level of expression in early TB
granulomas
Genes which showed significantly reduced expression in the
early TB granulomata, relative to normal lung tissues, included
Th2 chemokines (CCL14, 24, 25), MAP kinases (MKNK2,
MARK2, MAPK7, 11, 12, 15, 8IP3, 3K14, 3K6, BP1) calcium
binding/signaling proteins (CABP2, CABP4, CACNA2D3,
CAMK2A, CAMK2G, CAMKIIN, CALML3) and immune
signaling repressors/negative regulators (BCOR, NFKBIL1,
NFKBIL2, SOCS1, SOCS3) (Table S4).
Global expression analysis in NHP TB granuloma lesions,
13 weeks post-Mtb infection
The expression of 2,226 genes was significantly perturbed in late
(week 13) TB lesions relative to normal lung. Of these, 1259 genes
showed an enhanced level of expression (Table S5), while 967
genes showed a reduced level of expression (Table S6) in late
lesions. A short list of key immune genes whose expression was
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PLoS ONE | www.plosone.org 2 August 2010 | Volume 5 | Issue 8 | e12266Figure 1. Comparison of lymphocyte recruitment and activation in ‘‘early’’ and ‘‘late’’ TB granulomas. Flow cytometry analysis of BAL
samples from Mtb infected NHPs prior to infection (black bars), four weeks post-infection (clear bars) and 12 weeks post-infection (striped bars).
Comparison is shown for CD4
+ T cells (A), CD8
+ T cells (B), CD95
+ T cells (C), CD69
+ cells (D) and HLA-DR
+ cells (E). Results are expressed as percent of
total BAL cells.
doi:10.1371/journal.pone.0012266.g001
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respectively.
Genes with higher expression in late TB granulomas
The expression of very few chemokines, only one cytokine
(IL22RA1) and only one member of the interferon network (GIP3)
was significantly induced in these late lesions (Table S7). This was
in stark contrast to the early lesions, where the expression of
numerous chemokines, cytokines and IFNc and TNF networks
was induced (Table S3). The expression of A2M, BCOR,
BCL2L12, CD244, CD36, CD47, cyclins CCNL1, M1, T2,
cyclin-dependent kinases CDC2, 3, 9, 10, laminins LAMA3, A5,
B2 and B3, and immune regulators ARRB2, SOCS2, SOCS3,
TGFBI14 and TGFBR3 was significantly elevated in these late
lesions (Table S7).
Genes with lower expression in late TB granulomas
The expression of a vast majority of pro-inflammatory genes,
induced in early TB lesions, was repressed in late TB lesions,
relative to normal lung. These included numerous chemokines and
receptors (CCL2, 3, 5, 7, 11, 19; CXCL3, 6, 9, 10, 11, 12, 16,
receptors CCR1, CXCR4); cytokines and receptors (1A, 4I1,
10RA, 10RB, 15RA, 2RG, 21R, 27RA, 4R); the IFN network
(AR2, GR2, IRF1, IRF7, IRF8, ISG20, ISI30, IFI35, IFIT2,
INDO, JAK2); and the TNF network (SF13B, SF5, RSF12A,
RSF18, RSF1A, RSF4, RSF7, RSF8, AIP2, C1qTNF1, CD40,
LITAF, LTA, LTB) (Table S8).
The expression of ubiquitinating (UBD, UBE2C, UBE2E2,
UBE2G1, UBE2L6) and apoptotic proteins (AMID, BAK1, BAX,
BCL2L14, BCL3, BNIP1, CARD11, GZMA, GZMB, IER3,
PDCD2), cathepsins (CTSB, CTSC, CTSD, CTSS), transcrip-
tional regulators (CITED4, CEBPB, CEBPD, STAT1, SPIB);
complement components (C1R, C1QA, C1QB, C1S, C2, C4B);
cyclins (CCNE1, CCNF, CDKN1A), growth factors/receptors
(CSF1R, CSF2RA, CSF3R, ECGF1, FAP, FGF18, GDF15,
GRB2, IGFBP2, IGFBP3, IGFBP4, PF4, PTAFR, PGF, SCGF,
VGF), MHC antigens (HLA-A, -F, -DMA, -DPA1, -DQA1, -
DRA, -DRB1, -DRB3, -DRB4), metalloproteases (MMP1, 2, 3, 9,
19, 25, MT1X), signaling molecules (GPSM3, HCST, LAG3,
PRKCB1, RGS1, 16, 19, RARRES3, RIPK2, RIPK3, SLAMF1,
TCIRG1, TLR2, VDR), adhesion molecules (ICAM1, 4),
phospholipases (PLA1A, PLA2G4C, PLA2G7, PLCG2, PLD1);
proteinase inhibitors (SERPINA1, A3, B1, B9, E1, F2, H2), MAP
kinases (MAPK1, 2K1, 2K1IP1), RAS family members (RAB20,
31, 32, 5C, 7L1, RASSF4, RHOA, C, H, U, G3BP, RIS1) and
immune cell surface markers (CD3E, 6, 14, 37, 53, 68, 86, 180,
274, 300A) was also down regulated in these late lesions (Table
S8).
Transcriptome comparison of the ‘‘early’’ and ‘‘late’’ TB
lung lesions
The expression of hundreds of genes belonging to key immune
signaling pathways induced in early TB granulomas (Table S3)
was silenced in late lesions (Table S8). We therefore directly
compared the transcriptome of early and late TB granulomas in
NHPs. We found that the expression of ,1200 rhesus genes was
altered in late, relative to early lesions, in a statistically significant
manner. These differences are represented using a heat-map,
sorted on the basis of profile (k-means) clustering (Fig. 2). The host
genes contained in these ten distinct clusters are represented in
Table S9. Figure 3 represents the differences in gene expression in
early and late lesions between different immune specific categories,
including chemokines and receptors (Fig. 3A), cytokines and
receptors (Fig. 3B), and the IFNc (Fig. 3C) and TNF networks
(Fig. 3D).
While the expression of a majority of chemokine molecules was
induced early, the expression of CCL14, 24, 25 and 27 was higher
in late rather than early lesions (Fig 3A). Similarly, the expression
of cytokines/receptors IL1RL2, 17R, 17RE, 1F5 and 11RA, IFN
(PRKRA, IFIT1L, IFNA6) and TNF network (RSF11A, RSF16,
SF9, TRAF2 and 4) genes increased in late relative to early lesions.
The role played by these molecules needs to be studied in detail.
The expression of cytokine inhibitors SOCS2 and SOCS3 was
also induced in these late lesions, reflecting their role in controlling
pro-inflammatory responses.
Of the genes with significantly differential expression in either
early or late lesions, relative to normal lung tissue, only 20 genes
were commonly induced in both week 4 and week 13 lesions
(Fig 4A, Table S10). There was no significant pair wise association
between the up regulated transcriptome of early and late lesions.
In fact, the overlap (1.59%) was significantly lower than what
could be expected by chance. Similarly, of the potential 968 genes
that could overlap between those significantly down regulated in
early and late lesions, only four were commonly repressed in both
(Fig 4B, Table S11). Again, there was a lack of pair-wise
correlation in the down regulated transcriptome results from early
and late lesions. The overlap (0.41%) was again significantly lower
than what could be expected by chance. On the other hand, a
highly significant pair-wise association was observed between the
up regulated data set from early lesions and the down regulated
data set from the late lesions (Fig. 4C, Table S12). Out of the 968
genes that could potentially overlap between these data sets, 634
genes were common to both (64.46% overlap, x2=7458.18,
df=1, P,0.0000001). Similarly, a highly significant pair-wise
association was apparent between the set of genes down regulated
in week 4 lesions and the set of genes up regulated in the week 13
lesions (Fig. 4D, Table S13). Of the possible 1,259 genes that could
overlap these two data sets, the expression of 715 was down
regulated in week 4 lesions but up regulated in week 13 lesions
(x2=7109.56, df=1, P,0.0000001). These results underline our
assertion that a complete reprogramming of gene-expression
occurs over a course of 8–10 weeks during the maturation of newly
formed TB granulomas.
Confirmation of transcriptome results from early and late
TB lesions
We confirmed our microarray results by quantitatively analyz-
ing the expression of numerous chemokine ligands and receptors,
using RT-PCR arrays (Fig. 5). However, CCL25 was not included
in this array. The expression of this ligand was confirmed by
routine RT-PCR. The increased expression of all the chemokine
ligands and receptors from early lesions was confirmed by RT-
PCR. Similarly the expression of a majority of these genes was
repressed in late lesions, with the exception of CCL18 and
CCL25, which exhibited significantly more levels of expression in
late, relative to early lesions (Fig. 5). The expression of many other
related molecules that were present on the PCR array, including
TNF, TREM1, MMP7 and CKLF was also in agreement with
microarray results (not shown). To confirm the array results at the
protein level, we performed confocal multi-label immune fluores-
cence using antibodies specific for IL6 (Fig 6A) and TNF (Fig. 6B).
Sectioned granuloma samples from early and late stages were
profiled for the expression of these two antigens and the presence
of Mtb. Cells were detected by staining for TO-PRO-3, a nucleolar
marker. The left panel in Figure 6A clearly shows an extremely
high level of IL6 expression in early TB lesions, relative to the late
TB lesions in the right panel of the same figure. Similarly, the left
Primate TB Granulomas
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higher levels of TNF, relative to the right panel in the same figure,
where very few cells from a late lesion express TNF. These results
are consistent with our microarray observations. Not only was the
expression of IL6 and TNF lower in late lesions, but it was
confined to the outer edges of the generally circular granulomas.
This was in contrast to early lesions, where the expression of IL6
and TNF would be seen central areas of the lesions, in the vicinity
of Mtb infected macrophages. The load of Mtb in the BALs and the
lungs of week 4 animals were not higher than those of the week 13
animals (not shown). Therefore, these results are not due to the
clearance of Mtb from these animals. Rather, these results point to
the amelioration of inflammation in the lungs of late stage animals,
perhaps as a function of changes in bacterial physiology and the
resulting changes in its antigen profile.
Pathway analysis of ‘‘early’’ and ‘‘late’’ TB lung lesions
To visualize microarray data at a global level, we independently
uploaded lists of genes which exhibited statistically significant
differential gene expression in early as well as late lesions into
Ingenuity Pathways. We sought to determine which of the
established immune signaling pathways are perturbed to a level
significantly higher than what could be expected just by chance.
Pathway results mirror our assessment that the highly pro-
inflammatory environment of the early TB lesions is replaced by
an anti-inflammatory one in the late lesions. Pathways involved in
chemokine (Fig. S1A [early] & S1B [late]) and interferon signaling
(Fig. S2A & S2B), nitric oxide production (Fig. S3A & S3B), MHC
antigen presentation (Fig S4A & S4B) differentiation of T helper
cells (Fig. S5A & S5B) and maturation of DCs (Fig. S6A & S6B)
were significantly perturbed in both early and late lesions.
However, these pathways appeared to be turned on in early and
turned off in late lesions. These results demonstrate the system-
wide extent of transcriptional changes in these early and late
animals.
Discussion
The long-term control of TB requires a better understanding of
virulence and pathogenesis in appropriate animal models. The
architecture and organization of the NHP granulomas is highly
similar to those seen in humans. Such hypoxic and necrotizing
lesions are critical for containing Mtb replication [19]. Hypoxia
and necrosis may have a profound influence on the physiology of
Mtb, rendering a study of host-pathogen interactions in non-
hypoxic models misleading [20]. Characterization of primate TB
granulomas will allow a better understanding of latency and
reactivation. The view that granuloma formation is exclusively
mediated by the host immune system has recently been challenged
[21]. It is thought that Mtb may promote the granulomatous
response as it eventually allows the pathogen to survive in a
chronic state [21]. The study of primate granulomas is also
significant because of the potential to identify targets of host-
specific therapy against TB.
Figure 2. Hierarchical and profile cluster analysis of the transcriptome of early and late granulomas. Microarray analysis of genes
expressed in a differential manner between normal lung, and granulomas from Mtb infected NHPs at week 4 and week 13, using hierarchical (A) as
well as profile based (K-means) clustering (B). Clustering was performed using Spotfire DecisionSite for Functional Genomics, using data from
triplicate biological samples. The coloring scheme for the hierarchical cluster is white -no change in expression, blue – lower expression in lesion
samples relative to normal lung, and red – higher expression in lesion samples relative to normal lung. The hierarchical cluster is sorted by the results
obtained by dividing the dataset into 10 distinct K-means clusters, with the right column showing the identical color scheme as the k-means clusters
diagram.
doi:10.1371/journal.pone.0012266.g002
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early, and a late stage of infection by transcriptomics and pathways
analysis. Expression was confirmed by RT-PCR and confocal
microscopy. There are two important results. Firstly, early TB
granulomas in Mtb infected NHPs exhibited an immensely pro-
inflammatory profile. This result was expected, although the
breadth of this response, i.e. the comprehensive recruitment of
multiple and diverse immune signaling pathways in these lesion
tissues was surprising. Secondly, and more importantly, we found
that the initial pro-inflammatory response in these TB lesions is
almost entirely reversed within a matter of weeks. The breadth
and the rapid nature of this transcriptional reprogramming were
Figure 3. Clustering analysis of specific immune categories. Clustering analysis represents the differences in gene expression in early and late
lesions between specific immune categories: chemokines and their receptors (A), cytokines and their receptors (B), IFNc network (C) and TNF network
(D). The coloring scheme is white -no change in expression, blue – lower expression in lesion samples relative to normal lung, and red – higher
expression in lesion samples relative to normal lung. Each column represents results obtained from one distinct animal.
doi:10.1371/journal.pone.0012266.g003
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outcomes of TB depending upon the strain of Mtb as well as the
initial inoculum. Low-dose infection is supposed to cause latent TB
[11] while high-dose infection can lead to acute pulmonary TB
[11,15]. The accepted paradigm for the course of progression of
TB in a large majority of humans (,90%) and a large percentage
of NHPs (,50%) is that following initial infection, granulomatous
lesions control the spread and multiplication of Mtb. This leads to
fundamental changes in the pathogen’s metabolism and physiol-
ogy, establishing a dynamic where Mtb can be retained in a
chronic, persistent state.
Based on our results, we postulate that TB lesions reprogram
their physiological status over the course of time. Possibly, from
the pathogen’s standpoint, this reprogramming could involve the
induction of the known markers for persistence e.g. the hypoxia
induced DosRST regulon [22], and the repression of antigenic
Mtb virulence factors. This could in turn force the host to
reprogram its own response to the infection, by silencing pro-
inflammatory immune signaling pathways dependent on chemo-
kines, IFNc and TNF.
Genes with a higher expression in early granulomas
The induction of numerous chemokines in early TB lesions was
not surprising, since these chemokine gradients guide the various
immune effector cells to the site of infection. The induced
chemokines include the monocyte chemotactic CXCL3, the
lymphocyte chemotactic CXCL9, CXCL10 and CXCL11 [23]
and CXCL13. The expression of these genes is also induced in the
Mtb infected lungs of mice [24–26]. The expression of CXCL13
correlates with the recall response of the IL-17-producing CD4+ T
cells in mice vaccinated against and infected with Mtb [27]. The
expression of CCL3 and CCL4 was also significantly increased.
Increased expression of these two ligands has been observed
following Mtb infections in vitro, in vivo and in HIV/TB co-
infection [28–30]. These two CCR5 ligands may shape the
migration of DCs to and from the lymph nodes during infection
[31]. The role played by pro-inflammatory immune signaling
pathways involving IFNc and TNFa in protection against Mtb
infection is well understood [16]. The increased levels of various
immune cell surface markers and antigens presumably reflect the
migration of these cells to the cell dense granuloma (Table S1).
The expression of toll-receptor, defensin and complement genes is
indicative of the involvement of innate immune response in early
granulomatous response. Increased expression of a large number
of apoptotic genes reflects the attempt by the innate immune
system to contain infection by limiting the growth of Mtb, and
reveals the role played by the various caspases in this process. The
induction of metallothioneins and metalloproteases in early TB
lesions was particularly interesting. Recent studies have shown the
importance of MMP9 in interacting with Mtb secreted proteins
and inducing the formation of granuloma lesions [32]. Recent
reports have also suggested that the host ubiquitination machinery,
involved in tagging proteins for degradation, may also recognize
Mtb that escape from phagosomes [33]. This is reflected in the
induction of numerous genes encoding ubiquitination proteins in
early TB lesions.
Figure 4. Reprogramming of lesion transcriptome occurs in late, relative to early granulomas. Venn diagrams show the degree of
overlap between commonly up regulated (A) and commonly down regulated (B) genes between week 4 and week 13 granuloma lesions. Similarly,
overlap is also shown between genes up regulated in week 4 granulomas and down regulated in week 13 granulomas. Genes up regulated in various
analyses are represented in red while those down regulated in various analyses are represented in green. The analyses included genes induced or
repressed more than 2-fold in a statistically significant manner in all three ‘‘early’’ relative to ‘‘late’’ animals.
doi:10.1371/journal.pone.0012266.g004
Primate TB Granulomas
PLoS ONE | www.plosone.org 7 August 2010 | Volume 5 | Issue 8 | e12266Genes with lower expression in early TB granulomas
The expression of numerous MAP kinases, calcium binding/
signaling and immune signaling repressors/negative regulators was
repressed in early lesions, relative to normal lung. These novel
results likely reveal the immunomodulatory effects of Mtb on host
lungs. Bacterial infections can mobilize intracellular calcium that
favors pro-inflammatory responses [34]. It has been suggested that
one of the ways in which Mtb represses the pro-inflammatory
responses at the site of infection is by modulating the levels of Ca
2+
[34]. Our results likely reflect this phenomenon. Similarly, studies
have shown that MAP kinase signaling leads to reduced TNFa
expression during infection [35]. We propose that the early
repression of both calcium and MAPK signaling may, in part, be
responsible for the silencing of pro-inflammatory responses
observed at later stages.
Genes with higher expression in late TB granulomas
The expression of CCL18 has been shown to be induced by Mtb
infection of human macrophages [36]. Surprisingly, CCL18 was
one of the few chemokine ligands, whose expression was not
silenced in late lesions (Fig. 5, Tables S6, S8). The expression of
chemokines CCL24, CCL25 and CCL27 was in fact higher in late
Figure 5. Confirmation of transcriptome results by RT-PCR. Quantitative real-time Reverse-Transcriptase (RT-PCR) arrays specific for
chemokines and their receptors were used to confirm microarray results. Biologically independent samples from all three ‘‘early’’ and ‘‘late’’ animals
(different from those used in microarray experiment) were pooled into two groups, and duplicate analysis performed using PCR arrays. GAPDH was
used as the invariant housekeeping control for normalization. Numeric fold changes reflect the following difference: [Gene x lesion lung (week 4 or
week 13) – 18S RNA lesion lung (week 4 or week 13)] – [Gene x normal lung (week 4 or week 13) – 18S RNA lesion lung (week 4 or week 13)]. The
expression of CCL25 was checked by conventional SyBr green RT-PCR, using the Applied Biosystems (Foster City, CA) Fast SYBR Green kit since it was
not included in the PCR array. Data was analyzed in a manner comparable to PCR-arrays.
doi:10.1371/journal.pone.0012266.g005
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induced in early lesions but strongly induced at week 13, the
expression of CCL18 was induced at both stages. The role of these
chemokines in response to Mtb infection remains to be clarified. It
is possible that CCL18, CCL24, CCL25 and CCL27 negatively
regulate the function of other chemokines by competing for
common receptors. Alternatively, it is possible that they are
responsible for the chemotactic inclusion of specific immune
effector cell subtypes required to maintain granuloma structure.
Finally, it is possible that these chemokines are induced in response
to the production of alternative antigens by Mtb during persistent
growth. Interestingly, CCL25 is also expressed in small intestine,
and studies have shown that its expression, unlike other chemokine
ligands, is not enhanced by inflammatory stimuli and is
independent of signaling through the lymphotoxin a receptor
[37]. These results are concordant with our results which show
increased expression of CCL25 in late but not early lesions.
CCL25 is an important lymphocyte recruiter, particularly those
expressing a4b7, and its regulation is rather unique, involving
caudal homeo-box transcription factors [37]. While further
experiments are necessary, lung levels of CCL25 and its signaling
components may be of interest as markers of Mtb growth
restriction and latent TB.
Other genes with elevated expression in late TB lesions appear
to modulate the pro-inflammatory immune response. A2M codes
for alpha-2 macroglobulin, which interacts with cytokines to
down-regulate acute responses [38]); SOCS2 and SOCS3 are
suppressors of cytokine signaling; TGFBI14 and TGFBR3 belong
to the TGFB family. TGFBR3, in particular, acts as a reservoir for
the various members of the TGFB family of ligands at the cell
surface. Thus, its induction is indicative of the higher expression/
activity of these ligands. Other genes which were induced at this
time point are important, directly or indirectly, for the
perpetuation of Mtb virulence, including CD36 [39], CD47- an
integrin associated molecule involved in the increase in intracel-
lular Ca
2+, laminins - basolateral membrane components and
Figure 6. Confirmation of transcriptome results by confocal microscopy. Confocal microscopy shows differential expression of pro-
inflammatory cytokines IL6 (A) and TNFa (B) in week 4 (left panels) and week 13 (right panels) lesions. Immunofluorescence was performed on tissues
obtained from two animals – one ‘‘early’’ and one ‘‘late’’ animal.
doi:10.1371/journal.pone.0012266.g006
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BCOR- a co-repressor for the pro-apoptotic BCL6; BCL2L12-
which performs anti-apoptotic functions through G2/M arrest and
ARRB2, which silences activated G-protein signaling. Consistent
with the induction of ARRB2 in late lesions, the expression of
numerous G protein signaling molecules, which was elevated in
early lesions (Table S7), was silenced in late lesions (Table S8).
Genes with a lower expression in late TB lesions
The transcriptome observations from week 13 lesions indicate a
comprehensive silencing of the inflammatory response at the
chronic stage of the disease. This is manifested in the complete
reversal of the expression of chemokine, cytokine, IFN and TNF
gene families. Further, the silencing of immune cell markers may
reflect the progression of central necrosis at this time, causing the
death of macrophages and lymphocytes. This further leads to the
repression of key immune signaling pathways, involving growth
factors/receptors and immune relevant transcription factors.
Silencing of the apoptotic response in the lung lesions in this
chronic phase of TB may either reflect a lower antigenic load, or
an attempt by Mtb to actively silence the host pro-apoptotic
response in lung tissues, thus perpetuating the survival program of
the pathogen.
We show that the host mounts a massively inflammatory Th1-
type immune response to aerosol Mtb infection. This is
characterized by the recruitment of highly activated T-lympho-
cytes and macrophages to the lungs, and expression of IFNc, TNF,
cytokine and chemokine signaling pathways, four weeks post-
infection. Simultaneously, a significant increase in apoptotic
pathways was also observed. However, by week 13 post-infection,
the pro-inflammatory response was largely silenced, even though
the animals continued to exhibit clinical signs of active TB.
Instead, these lesions are characterized by a Th2-type response.
This suggests the existence of a complex balance between pro- and
anti-inflammatory responses, which determine the progression of
the granulomatous response.
While we are excited by our results, indeed these experiments
represent only the first steps in the complete molecular
characterization of primate TB granuloma lesions. A granuloma
is a complex entity with multiple immune cell types participating.
In future experiments, it would be important to completely
characterize the cellular source of these observed gene-expression
changes. By separating the various cell types in live granulomas,
and the application of flow-cytometry, transcriptomics and
confocal microscopy, we have recently begun to address this
question. Another question to be answered is how co-infection
with AIDS negatively impacts the transcriptional characteristics of
these primate lesions. As an extension, one could study if prior
protective vaccination, e.g. with BCG, could positively impact the
lesion character. These studies could promote our understanding
of the individual correlates of protection against TB.
Methods
Ethics Statement
The Tulane National Primate Research Center facilities are
accredited by the American Association for Accreditation of
Laboratory Animal Care and licensed by the US Department of
Agriculture. All animals were routinely cared for according to the
guidelines prescribed by the NIH Guide to Laboratory Animal
Care. NHP studies were conducted following the recommenda-
tions of the institutional animal care and use committee. Humane
endpoints were pre-defined in this protocol and applied as a
measure of reduction of discomfort.
NHP infection and veterinary procedures
Mtb infection, clinical management of TB and necropsy of
NHPs have been described [15].
Flow cytometry
BAL sample was collected in normal saline containing 10%
(final) fetal bovine serum. The cells were washed and suspended in
complete RPMI-10. All lymphocytes were .90% viable by trypan
blue dye exclusion method. BAL cells from three NHPs were
stained and analyzed using previously described protocols [41].
Polychromatic flow cytometry was performed on FACSAria (BD
Biosciences) using PE-Texas Red, PE-Cy7, APC-Cy7, Pacific Blue
and Qdot655 as the available fluorophores. Monoclonal antibod-
ies CD3 (SP32-2), CD69 (FN50), HLA-DR (L243) were obtained
from BD Biosciences. CD8 PE-Texas red (MHCD0817) and CD4
Qdot655 (T4/19Thy5D7) were obtained from Caltag Laborato-
ries and the NIH Nonhuman Primate Reagent Resource courtesy
of Dr. K. Reimann (Harvard) respectively. Data was analyzed
using the FlowJo software (TreeStar) version 8.8.6.
DNA Microarrays
Numerous surgically excised granulomatous lesion and non-
granulomatous areas of lung tissue were obtained, 4 and 13 weeks
post-Mtb infection. A total of three animals were profiled for each
time point using microarrays. Lesions from the same animal were
pooled and transcriptome profiled relative to the total pool of non-
granulomatous ‘‘normal’’ lung. Pools contained lesion tissues from
the same animal. As controls, we also obtained lung tissue sections
from normal, uninfected animals. RNA was isolated from fresh
lung using the RiboPure kit (Ambion), and profiled using macaque
whole genome 4x44 k microarrays (Agilent Technologies). Raw
array results from our experiments can be retrieved from the Gene
Expression Omnibus (GPL10183). A stringent set of criteria
applied to remove erroneous data from consideration [42].
Remaining data was log2 transformed and normalized using
Locally Weighted Scatter-plot Smoothing in Spotfire S
+. Genes
were considered to be differentially expressed if they exhibited a 2-
fold perturbation in gene expression magnitude in each of the
three biological replicates, in a statistically significant manner
(P,0.05). Statistical analysis of pair-wise association within
different data sets was performed through a chi-squared test,
using STATISTICA (Statsoft). Gene-sets from 4 and 13 week
lesions were uploaded to Ingenuity Pathways Analysis (IPA)
database (Ingenuity Systems, Redwood City, CA), and statistically
significant changes in immune signaling pathways were cata-
logued.
Confirmation of transcriptome results by RT-PCR and
confocal microscopy
To validate transcriptome results, we performed quantitative
RT-PCR on chemokine receptors and ligands using a pathway
specific RT2Profiler PCR array (SABiosciences). Multilabel
immune-fluorescence confocal microscopy has been described
earlier [15]. In order to assay for the expression of specific
antigens, antibodies against IL6 (ProSpec-Tany #mAHuIL6,
made in mouse, 1:2000 dilution) and TNFa (Becton Dickenson
#558882, made in mouse, 1:10 dilution) were labeled with Alexa
Fluor 488 secondary antibodies. Mtb were detected using an
antibody from Biocare Medical #CP140, made in rabbit and used
at a 1:100 dilution, and detected with an Alexa Fluor 568
secondary antibody. Host cells were revealed by labeling with a
nuclolear marker (TO-PRO-3 iodide from Invitrogen #T-3605).
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All animal procedures were approved by the Tulane Institu-
tional Animal Care and Use Committee (IACUC). All procedures
related to Mtb were approved by the Tulane Institutional Biosafety
Committee (IBC). DNA Microarray data associated with this
manuscript can be obtained from Gene Expression Omnibus
(accession number GPL10183).
Supporting Information
Table S1 This table contains a comprehensive list of all NHP
genes with a higher expression in a statistically significant manner,
in early (week 4) TB lesions, relative to normal lungs.
Found at: doi:10.1371/journal.pone.0012266.s001 (0.25 MB
PDF)
Table S2 This table contains a comprehensive list of all NHP
genes with a lower expression in a statistically significant manner,
in early (week 4) TB lesions, relative to normal lungs.
Found at: doi:10.1371/journal.pone.0012266.s002 (0.26 MB
PDF)
Table S3 DNA Microarray Analysis: Immune function genes
with significantly enhanced expression in Mtb granuloma’s relative
to non-granulomatous tissue four week’s post-infection. Symbol =
Official NCBI human gene symbol associated with that gene. P =
p value of significance in a t-test.
Found at: doi:10.1371/journal.pone.0012266.s003 (0.02 MB
DOCX)
Table S4 DNA Microarray Analysis: Immune function genes
with significantly reduced expression in Mtb granuloma’s relative
to non-granulomatous tissue four week’s post-infection. Symbol =
Official NCBI human gene symbol associated with that gene. P =
p value of significance in a t-test.
Found at: doi:10.1371/journal.pone.0012266.s004 (0.02 MB
DOCX)
Table S5 This table contains a comprehensive list of all NHP
genes with a higher expression in a statistically significant manner,
in late (week 13) TB lesions, relative to normal lungs.
Found at: doi:10.1371/journal.pone.0012266.s005 (0.21 MB
PDF)
Table S6 This table contains a comprehensive list of all NHP
genes with a lower expression in a statistically significant manner,
in late (week 13) TB lesions, relative to normal lungs.
Found at: doi:10.1371/journal.pone.0012266.s006 (0.20 MB
PDF)
Table S7 DNA Microarray Analysis: Immune function genes
with significantly enhanced expression in Mtb granuloma’s relative
to non-granulomatous tissue four week’s post-infection. Symbol =
Official NCBI gene symbol associated with that gene. P = p value
of significance in a student’s t-test.
Found at: doi:10.1371/journal.pone.0012266.s007 (0.01 MB
DOCX)
Table S8 DNA Microarray Analysis: Immune function genes
with significantly reduced expression in Mtb granuloma’s relative
to non-granulomatous tissue four week’s post-infection. Symbol =
Official NCBI gene symbol associated with that gene. P = p value
of significance in a student’s t-test.
Found at: doi:10.1371/journal.pone.0012266.s008 (0.02 MB
DOCX)
Table S9 This table contains the detailed composition of all 10
K-means clusters defined in the statistically significant data set
between early and late lesions.
Found at: doi:10.1371/journal.pone.0012266.s009 (1.02 MB
PDF)
Table S10 This table contains genes with a higher expression in
both early and late lesions (i.e. the overlapping genes in Fig. 4A).
Found at: doi:10.1371/journal.pone.0012266.s010 (0.05 MB
PDF)
Table S11 This table contains genes with a lower expression in
both early and late lesions (i.e. the overlapping genes in Fig. 4B).
Found at: doi:10.1371/journal.pone.0012266.s011 (0.05 MB
PDF)
Table S12 This table contains genes with a higher expression in
early but a lower expression in late lesions (i.e. the overlapping
genes in Fig. 4C).
Found at: doi:10.1371/journal.pone.0012266.s012 (0.13 MB
PDF)
Table S13 This table lists genes with a lower expression in early
but a higher expression in late genes (i.e. the overlapping genes in
Fig. 4D).
Found at: doi:10.1371/journal.pone.0012266.s013 (0.11 MB
PDF)
Figure S1 Comparison of the chemokine signaling pathway in
early and late TB granulomas. Canonical pathways contained
within the IPA algorithm were queried with the list of genes
significantly up (red) or down (green) regulated in week 4 or week
13 lesions. Pathway illustrations are shown for week 4 (A) and
week 13 (B) lesions.
Found at: doi:10.1371/journal.pone.0012266.s014 (0.75 MB TIF)
Figure S2 Comparison of the interferon signaling pathway in
early and late TB granulomas. Canonical pathways contained
within the IPA algorithm were queried with the list of genes
significantly up (red) or down (green) regulated in week 4 or week
13 lesions. Pathway illustrations are shown for week 4 (A) and
week 13 (B) lesions.
Found at: doi:10.1371/journal.pone.0012266.s015 (1.43 MB TIF)
Figure S3 Comparison of the nitric oxide production pathway
in early and late TB granulomas. Canonical pathways contained
within the IPA algorithm were queried with the list of genes
significantly up (red) or down (green) regulated in week 4 or week
13 lesions. Pathway illustrations are shown for week 4 (A) and
week 13 (B) lesions.
Found at: doi:10.1371/journal.pone.0012266.s016 (0.96 MB TIF)
Figure S4 Comparison of the MHC antigen presentation
pathway in early and late TB granulomas. Canonical pathways
contained within the IPA algorithm were queried with the list of
genes significantly up (red) or down (green) regulated in week 4 or
week 13 lesions. Pathway illustrations are shown for week 4 (A)
and week 13 (B) lesions.
Found at: doi:10.1371/journal.pone.0012266.s017 (1.40 MB TIF)
Figure S5 Comparison of the T-helper cell differentiation
pathway in early and late TB granulomas. Canonical pathways
contained within the IPA algorithm were queried with the list of
genes significantly up (red) or down (green) regulated in week 4 or
week 13 lesions. Pathway illustrations are shown for week 4 (A)
and week 13 (B) lesions.
Found at: doi:10.1371/journal.pone.0012266.s018 (1.46 MB TIF)
Figure S6 Comparison of the DC maturation pathway in early
and late TB granulomas. Canonical pathways contained within
the IPA algorithm were queried with the list of genes significantly
up (red) or down (green) regulated in week 4 or week 13 lesions.
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lesions.
Found at: doi:10.1371/journal.pone.0012266.s019 (3.22 MB TIF)
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